| Literature DB >> 30612504 |
Alexander Verevkin1, Konstantin von Aspern1, Sergey Leontyev1, Sven Lehmann1, Michael A Borger1, Piroze M Davierwala1.
Abstract
Background Iatrogenic coronary artery injuries during percutaneous coronary interventions ( PCI ) often require emergent surgical management. Our study evaluated the early and long-term outcomes in patients undergoing surgical treatment of iatrogenic PCI complications and identified the predictors of operative and long-term mortality. Methods and Results Pre-, intra- and post-operative data and hospital outcomes of 168 consecutive patients undergoing cardiac surgical procedures for iatrogenic complications following PCI between December 1999 and July 2015, were prospectively collected in our computerized database. Logistic and Cox regression analyses were used to identify the independent predictors of operative and long-term mortality. The mean age was 68.5±10.2 years and 35.7% were females. PCI complications included left anterior descending (38.7%), right coronary (29.2%), circumflex (13.1%), left main coronary artery injuries (19.0%), and acute myocardial infarction (66.7%), Type A aortic dissection (7.7%), cardiac tamponade (17.9%), and cardiogenic shock ( CS ) (46.4%). Operative mortality for corrective surgery was 20.8% and was independently predicted by critical preoperative state (odds ratio: 3.5; P=0.01). The 5- and 10-year survival for all patients was 63.9±4.0% and 49.6±5.0%, which improved remarkably in hospital survivors (79.0±4.0% and 64.0±6.0%). Risk factors for long-term mortality were critical preoperative state (hazard ratio: 3.5; P<0.0001) and coronary artery occlusion during PCI (hazard ratio: 2.6; P=0.002). The 5- and 10-year freedom from major adverse cardiac and cerebrovascular events was 59.7±4.0% and 41.9±5.0%. Conclusions Iatrogenic injuries after PCI or coronary angiography requiring surgical correction are associated with a high operative and long-term mortality. Patients developing acute coronary artery occlusion have a more guarded long-term prognosis. Hospital survivors, however, have a superior long-term survival.Entities:
Keywords: aortic surgery; complication; coronary artery bypass graft surgery; percutaneous coronary intervention; surgery
Mesh:
Year: 2019 PMID: 30612504 PMCID: PMC6405713 DOI: 10.1161/JAHA.118.010940
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Preoperative Data
| Preoperative Variables | All Patients, n=168 |
|---|---|
| Age, y (mean±SD) | 68.5±10.2 |
| Female sex, n (%) | 60 (35.7) |
| Cardiac risk factors, n (%) | |
| Diabetes mellitus | 54 (32.1) |
| Systemic hypertension | 158 (94.0) |
| Hyperlipidemia | 104 (61.9) |
| Smoker | 56 (33.3) |
| Comorbidities | |
| Chronic obstructive pulmonary disease, n (%) | 12 (7.0) |
| Stroke, n (%) | 15 (8.9) |
| Peripheral vascular disease, n (%) | 30 (17.9) |
| Glomerular filtration rate, mL/min per 1.73 m2 (mean±SD) | 71±37 |
| Cardiac parameters | |
| Previous myocardial infarction (>90 d), n (%) | 31 (18.5) |
| Left ventricular ejection fraction, % | 52±16 |
| Triple vessel disease, n (%) | 74 (44.0) |
| Left main disease, n (%) | 31 (18.4) |
| Primary indication for PCI or coronary angiography, n (%) | |
| Stable angina pectoris | 98 (58.3) |
| Acute coronary syndrome | 62 (36.9) |
| Asymptomatic at time of coronary angiography | 8 (4.8) |
| Site of intervention, n (%) | |
| In hospital | 133 (79.2) |
| Referral center | 35 (20.8) |
| Clinical and hemodynamic status following PCI complications, n (%) | |
| Myocardial infarction after PCI complication | 112 (66.7) |
| ST‐segment–elevation myocardial infarction | 87 (51.8) |
| Non–ST‐segment–elevation myocardial infarction | 25 (14.9) |
| Cardiac tamponade | 26 (15.5) |
| Inotropic support | 114 (67.8) |
| High dose of inotropic support | 65 (38.7) |
| Critical preoperative state | 96 (57.1) |
| Resuscitation | 34 (20.2) |
| Ventilation | 26 (15.6) |
| Cardiogenic shock | 78 (46.4) |
| Lactate level, mmols/L (mean±SD) | 3.3±4.1 |
| ECMO implantation | 6 (3.5) |
| IABP implantation | 19 (11.3) |
| Time interval from PCI to surgery, min (mean±SD) | 167±107 |
ECMO indicates extracorporeal oxygenation; IABP, intra‐aortic balloon pump implantation; PCI, percutaneous coronary implantation.
Anticoagulation Therapy Immediately Before Surgery
| Drugs, n (%) | All Patients, n=168 |
|---|---|
| Single drug | |
| Aspirin | 17 (10.1) |
| Heparin | 19 (11.3) |
| Newer oral anticoagulants | 5 (2.9) |
| Combination of drugs | |
| Aspirin+newer oral anticoagulants | 2 (1.2) |
| Aspirin+glycoprotein IIb/IIIa inhibitors | 3 (1.8) |
| Aspirin+P2Y12 inhibitors | 39 (23.2) |
| Aspirin+heparin | 39 (23.2) |
| Aspirin+glycoprotein IIb/IIIa inhibitors+P2Y12 inhibitors | 7 (4.2) |
| Aspirin+glycoprotein IIb/IIIa inhibitors+P2Y12 inhibitors+heparin | 7 (4.2) |
| Aspirin+P2Y12 inhibitors+heparin | 21 (12.5) |
| Aspirin+glycoprotein IIb/IIIa inhibitors+heparin | 4 (2.4) |
| Glycoprotein IIb/IIIa inhibitors+heparin | 4 (2.4) |
| No anticoagulation | 1 (0.6) |
Figure 1Trends in incidence of complications and operative mortality over the time‐frame of the study.
Indications for Emergency Surgery
| Indications, n (%) | All Patients, n=168 |
|---|---|
| Type A aortic dissection | 13 (7.7) |
| Hemopericardium causing cardiac tamponade | 30 (17.9) |
| Complications involving coronary arteries, n (%) | |
| Lesion location | |
| Left anterior descending artery territory, n (%) | 65 (38.7) |
| Right coronary artery territory, n (%) | 49 (29.2) |
| Left main stem territory, n (%) | 32 (19.0) |
| Circumflex artery territory, n (%) | 22 (13.1) |
| Multiple locations, n (%) | 21 (12.5) |
| Lesion type | |
| Dissection, n (%) | 126 (75.0) |
| Occlusion, n (%) | 32 (19.0) |
| Perforation, n (%) | 19 (11.3) |
| Stent dislocation, n (%) | 8 (4.8) |
| Irretrievable guide wire, n (%) | 3 (1.8) |
| Combination of lesions | 56 (33.3) |
Intraoperative Data
| Intraoperative Data | All Patients, n=168 |
|---|---|
| Length of surgery, min (mean±SD) | 173±98 |
| Cardiopulmonary bypass time, min (mean±SD) | 65±71 |
| Aortic cross‐clamp time, min (mean±SD) | 19±35 |
| Operative procedures, n (%) | |
| CABG surgery | 148 (88.1) |
| Off‐pump CABG | 51 (34.5) |
| On‐pump CABG, beating heart | 44 (29.7) |
| On‐pump CABG, arrested heart | 53 (35.8) |
| Conversion from off‐ to on‐pump CABG | 2 (1.4) |
| LIMA‐LAD bypass grafting | 95 (64.2) |
| Incomplete revascularization | 18 (12.2) |
| Aortic surgery | 13 (7.7) |
| Isolated ascending aorta replacement | 6 (3.6) |
| Partial/total aortic arch repair | 7 (4.2) |
| Reconstruction of the sinus Valsalva | 1 (0.6) |
| Valve surgery | 3 (1.8) |
| Aortic valve replacement | 2 (1.2) |
| Mitral valve replacement | 1 (0.6) |
| Exploratory sternotomy | 19 (11.4) |
| Suture repair of injured myocardium | 12 (7.2) |
CABG indicates coronary artery bypass graft; LAD, left anterior descending artery; LIMA, left internal mammary artery.
Postoperative Outcomes
| Outcomes | All Patients, n=168 (%) |
|---|---|
| Operative mortality, n (%) | 35 (20.8) |
| Low‐output syndrome, n (%) | 54 (32.0) |
| Postoperative IABP implantation, n (%) | 36 (24.0) |
| Postoperative ECMO, n (%) | 20 (12.0) |
| Postoperative myocardial infarction, n (%) | 9 (54.0) |
| Stroke, n (%) | 16 (9.5) |
| Sepsis, n (%) | 4 (2.3) |
| New onset dialysis‐dependent renal failure | 31 (18.4) |
| Respiratory failure, n (%) | 43 (25.6) |
| Cardiopulmonary resuscitation, n (%) | 17 (10.1) |
| Gastrointestinal complications, n (%) | 15 (8.9) |
| Re‐exploration for bleeding, n (%) | 9 (5.4) |
| Platelet transfusion, mean±SD | 1.9±3.9 |
| Packed red blood cell transfusion, mean±SD | 8.6±13.7 |
| Fresh frozen plasma transfusion, mean±SD | 6.4±11.6 |
ECMO indicates extracorporeal membrane oxygenation; IABP, intra‐aortic balloon pump.
Figure 2Cumulative survival for all patients.
Figure 3Cumulative survival for survivors (after exclusion of operative mortality).
Figure 4Freedom from major cardiac and cerebrovascular events for all patients. MACCE indicates major adverse cardiac and cerebrovascular events.